UCI – Das Tumorzentrum Bern - Navigation
{"headers":{"title":"Title","year":"Year","type":"Type"},"rows":[{"title":"Schnegg-Kaufmann, A. S., Bacher, U., Rov\u00f3, A., Andres, M., Wiedemann, G., Porret, N., Moshaver, B., Kaufmann, N., Tchinda, J., Meyer, S. C., \u0026 Angelillo-Scherrer, A. (2025). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/223987\u0022\u003EArtificial Intelligence in Haematologic Diagnostics: Current Applications and Future Perspectives\u003C\/a\u003E. \u003Ci\u003EActa Haematologica\u003C\/i\u003E, 1-14.","year":2025,"type":"Journal Article (Further Contribution)"},{"title":"Tsakiris, D. A., Gavriilaki, E., Chanou, I., \u0026 Meyer, S. C. (2024). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/179150\u0022\u003EHemostasis and complement in allogeneic hematopoietic stem cell transplantation: clinical significance of two interactive systems.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EBone Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E59\u003C\/i\u003E(10), 1349-1359.","year":2024,"type":"Journal Article (Review)"},{"title":"Dunbar, A. J., Bowman, R. L., Park, Y. C., O\u2019Connor, K., Izzo, F., Myers, R. M., Karzai, A., Zaroogian, Z., Kim, W. J., Fernandez-Maestre, I., Waarts, M. R., Nazir, A., Xiao, W., Codilupi, T., Brodsky, M., Farina, M., Cai, L., Cai, S. F., Wang, B., \u2026 Levine, R. L. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/173485\u0022\u003EJak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms\u003C\/a\u003E. \u003Ci\u003ECancer Discovery\u003C\/i\u003E, \u003Ci\u003E14\u003C\/i\u003E(5), 737-751.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Codilupi, T., Szybinski, J., Arunasalam, S., Jungius, S., Dunbar, A. C., Stivala, S., Brkic, S., Albrecht, C., Vokalova, L., Yang, J. L., Buczak, K., Ghosh, N., Passweg, J. R., Rov\u00f3, A., Angelillo, A., Pankov, D., Dirnhofer, S., Levine, R. L., Koche, R., \u0026 Meyer, S. C. (2024). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/171645\u0022\u003EDevelopment of resistance to type II JAK2 inhibitors in MPN depends on AXL kinase and is targetable\u003C\/a\u003E. \u003Ci\u003EClinical Cancer Research\u003C\/i\u003E, \u003Ci\u003E30\u003C\/i\u003E(3), 586-599.","year":2024,"type":"Journal Article (Original Article)"},{"title":"Konantz, M., Williams, M., Merkel, T., Reiss, A., Dirnhofer, S., Meyer, S. C., Valent, P., George, T. I., Tzankov, A., \u0026 Hartmann, K. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/168579\u0022\u003EIncreased TIM-3 and GAL-9 serum levels in patients with advanced systemic mastocytosis\u003C\/a\u003E. \u003Ci\u003EJournal of Allergy and Clinical Immunology\u003C\/i\u003E, \u003Ci\u003E152\u003C\/i\u003E(4), 1019-1024.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Jungius, S., Adam, F. C., Grosheintz, K., Medinger, M., Buser, A., Passweg, J. R., Halter, J. P., \u0026 Meyer, S. C. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/169573\u0022\u003ECharacterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes\u003C\/a\u003E. \u003Ci\u003EFrontiers in Oncology\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(1205387), 1205387.","year":2023,"type":"Journal Article (Original Article)"},{"title":"Konantz, M., Merkel, T., Meyer, S. C., \u0026 Hartmann, K. (2023). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/121486\u0022\u003EMRGPRX2: A\u00a0novel biomarker in mastocytosis\u003C\/a\u003E? \u003Ci\u003EThe Journal of Allergy and Clinical Immunology. In Practice\u003C\/i\u003E, \u003Ci\u003E11\u003C\/i\u003E(2), 669-671.","year":2023,"type":"Journal Article (Further Contribution)"},{"title":"Kirsch, M., Stehle, G. T., Konantz, M., Passweg, J., Dirnhofer, S., Meyer, S. C., \u0026 Hartmann, K. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/115822\u0022\u003EPresence of neoplastic mast cells in ascites in advanced systemic mastocytosis\u003C\/a\u003E. \u003Ci\u003EThe Journal of Allergy and Clinical Immunology. In Practice\u003C\/i\u003E, \u003Ci\u003E10\u003C\/i\u003E(11), 3035-3038e1.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Parmigiani, E., Ivanek, R., Rolando, C., Hafen, K., Turchinovich, G., Lehmann, F. M., Gerber, A., Brkic, S., Frank, S., Meyer, S. C., Wakimoto, H., G\u00fcnel, M., Louvi, A., Mariani, L., Finke, D., Holl\u00e4nder, G., Hutter, G., Tussiwand, R., Taylor, V., \u0026 Giachino, C. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/115826\u0022\u003EInterferon-\u03b3 resistance and immune evasion in glioma develop via Notch-regulated co-evolution of malignant and immune cells\u003C\/a\u003E. \u003Ci\u003EDevelopmental Cell\u003C\/i\u003E, \u003Ci\u003E57\u003C\/i\u003E(15), 1847-1865e9.","year":2022,"type":"Journal Article (Original Article)"},{"title":"Adam, F. C., Szybinski, J., Halter, J. P., Cantoni, N., Wenzel, F., Leonards, K., Brkic, S., Passweg, J. R., Touw, I., Maxson, J. E., \u0026 Meyer, S. C. (2022). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172376\u0022\u003ECo-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia\u003C\/a\u003E. \u003Ci\u003ECurrent Oncology\u003C\/i\u003E, \u003Ci\u003E29\u003C\/i\u003E(2), 805-815.","year":2022,"type":"Journal Article (Further Contribution)"},{"title":"Bader, M. S., \u0026 Meyer, S. C. (2022). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172374\u0022\u003EJAK2 in Myeloproliferative Neoplasms: Still a Protagonist.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EPharmaceuticals\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(2).","year":2022,"type":"Journal Article (Review)"},{"title":"Person, F., Meyer, S. C., Hopfer, H., \u0026 Menter, T. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172379\u0022\u003ERenal post-mortem findings in myeloproliferative and myelodysplastic\/myeloproliferative neoplasms\u003C\/a\u003E. \u003Ci\u003EVirchows Archiv\u003C\/i\u003E, \u003Ci\u003E479\u003C\/i\u003E(5), 1013-1020.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Stivala, S., \u0026 Meyer, S. C. (2021). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172377\u0022\u003ERecent Advances in Molecular Diagnostics and Targeted Therapy of Myeloproliferative Neoplasms.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ECancers\u003C\/i\u003E, \u003Ci\u003E13\u003C\/i\u003E(20).","year":2021,"type":"Journal Article (Review)"},{"title":"Brkic, S., Stivala, S., Santopolo, A., Szybinski, J., Jungius, S., Passweg, J. R., Tsakiris, D., Dirnhofer, S., Hutter, G., Leonards, K., Tschanz-Lischer, H. E. L., Dettmer, M., Neel, B. G., Levine, R. L., \u0026 Meyer, S. C. (2021). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/57650\u0022\u003EDual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy\u003C\/a\u003E. \u003Ci\u003ELeukemia\u003C\/i\u003E, \u003Ci\u003E35\u003C\/i\u003E(10), 2875-2884.","year":2021,"type":"Journal Article (Original Article)"},{"title":"Zeeh, F. C., \u0026 Meyer, S. C. (2021). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172378\u0022\u003ECurrent Concepts of Pathogenesis and Treatment of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EH\u00e4mostaseologie\u003C\/i\u003E, \u003Ci\u003E41\u003C\/i\u003E(3), 197-205.","year":2021,"type":"Journal Article (Review)"},{"title":"Szybinski, J., \u0026 Meyer, S. C. (2021). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172380\u0022\u003EGenetics of Myeloproliferative Neoplasms.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EHematology\/Oncology\/Clinics\/of\/North\/America\u003C\/i\u003E, \u003Ci\u003E35\u003C\/i\u003E(2), 217-236.","year":2021,"type":"Journal Article (Review)"},{"title":"Brkic, S., \u0026 Meyer, S. C. (2021). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172381\u0022\u003EChallenges and Perspectives for Therapeutic Targeting of Myeloproliferative Neoplasms.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EHemaSphere\u003C\/i\u003E, \u003Ci\u003E5\u003C\/i\u003E(1), e516.","year":2021,"type":"Journal Article (Review)"},{"title":"Nienhold, R., Ashcroft, P., Zmajkovic, J., Rai, S., Rao, T. N., Drexler, B., Meyer, S. C., Lundberg, P., Passweg, J. R., Lekovi\u0107, D., \u010coki\u0107, V., Bonhoeffer, S., \u0026 Skoda, R. C. (2020). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172383\u0022\u003EMPN patients with low mutant JAK2 allele burden show late expansion restricted to erythroid and megakaryocytic lineages\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E136\u003C\/i\u003E(22), 2591-2595.","year":2020,"type":"Journal Article (Further Contribution)"},{"title":"Stivala, S., Codilupi, T., Brkic, S., Baerenwaldt, A., Ghosh, N., Hao-Shen, H., Dirnhofer, S., Dettmer, M., Simillion, C., Kaufmann, B. A., Chiu, S., Keller, M., Kleppe, M., Hilpert, M., Buser, A. S., Passweg, J. R., Radimerski, T., Skoda, R. C., Levine, R. L., \u0026 Meyer, S. C. (2019). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/182157\u0022\u003ETargeting compensatory MEK\/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms\u003C\/a\u003E. \u003Ci\u003EThe Journal of Clinical Investigation\u003C\/i\u003E, \u003Ci\u003E129\u003C\/i\u003E(4), 1596-1611.","year":2019,"type":"Journal Article (Original Article)"},{"title":"Meyer, S. C., Drexler, B., \u0026 Skoda, R. C. (2019). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172385\u0022\u003E[Myeloproliferative neoplasms - Update on diagnosis and treatment].\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ETherapeutische Umschau. Revue Therapeutique\u003C\/i\u003E, \u003Ci\u003E76\u003C\/i\u003E(9), 487-495.","year":2019,"type":"Journal Article (Review)"},{"title":"Kunimoto, H., Meydan, C., Nazir, A., Whitfield, J., Shank, K., Rapaport, F., Maher, R., Pronier, E., Meyer, S. C., Garrett-Bakelman, F. E., Tallman, M., Melnick, A., Levine, R. L., \u0026 Shih, A. H. (2018). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172386\u0022\u003ECooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor Sensitivity\u003C\/a\u003E. \u003Ci\u003ECancer Cell\u003C\/i\u003E, \u003Ci\u003E33\u003C\/i\u003E(1), 44-59e8.","year":2018,"type":"Journal Article (Original Article)"},{"title":"Stivala, S., Gobbato, S., Infanti, L., Reiner, M. F., Bonetti, N., Meyer, S. C., Camici, G. G., L\u00fcscher, T. F., Buser, A., \u0026 Beer, J. H. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172388\u0022\u003EIn response to the comment by Hechler et al.: Amotosalen\/UVA pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E102\u003C\/i\u003E(12), e504-e505.","year":2017,"type":"Journal Article (Further Contribution)"},{"title":"Nitulescu, I. I., Meyer, S. C., Wen, Q. J., Crispino, J. D., Lemieux, M. E., Levine, R. L., Pelish, H. E., \u0026 Shair, M. D. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172387\u0022\u003EMediator Kinase Phosphorylation of STAT1 S727 Promotes Growth of Neoplasms With JAK-STAT Activation\u003C\/a\u003E. \u003Ci\u003EEBioMedicine\u003C\/i\u003E, \u003Ci\u003E26\u003C\/i\u003E, 112-125.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Stivala, S., Gobbato, S., Infanti, L., Reiner, M. F., Bonetti, N., Meyer, S. C., Camici, G. G., L\u00fcscher, T. F., Buser, A., \u0026 Beer, J. H. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172391\u0022\u003EAmotosalen\/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance\u003C\/a\u003E. \u003Ci\u003EHaematologica - the Hematology Journal\u003C\/i\u003E, \u003Ci\u003E102\u003C\/i\u003E(10), 1650-1660.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Meyer, S. C. (2017). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172389\u0022\u003EMechanisms of Resistance to JAK2 Inhibitors in Myeloproliferative Neoplasms.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EHematology\/Oncology\/Clinics\/of\/North\/America\u003C\/i\u003E, \u003Ci\u003E31\u003C\/i\u003E(4), 627-642.","year":2017,"type":"Journal Article (Review)"},{"title":"Meyer, S. C., Steinmann, E., Lehmann, T., Muesser, P., Passweg, J. R., Skoda, R. C., \u0026 Tsakiris, D. A. (2017). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172390\u0022\u003EAnti-Platelet Factor 4\/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera\u003C\/a\u003E. \u003Ci\u003EBioMed Research International\u003C\/i\u003E, \u003Ci\u003E2017\u003C\/i\u003E, 9876819.","year":2017,"type":"Journal Article (Original Article)"},{"title":"Grisouard, J., Li, S., Kubovcakova, L., Rao, T. N., Meyer, S. C., Lundberg, P., Hao-Shen, H., Romanet, V., Murakami, M., Radimerski, T., Dirnhofer, S., \u0026 Skoda, R. C. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172393\u0022\u003EJAK2 exon 12 mutant mice display isolated erythrocytosis and changes in iron metabolism favoring increased erythropoiesis\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E128\u003C\/i\u003E(6), 839-851.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Shimizu, T., Kubovcakova, L., Nienhold, R., Zmajkovic, J., Meyer, S. C., Hao-Shen, H., Geier, F., Dirnhofer, S., Guglielmelli, P., Vannucchi, A. M., Feenstra, J. D. M., Kralovics, R., Orkin, S. H., \u0026 Skoda, R. C. (2016). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172392\u0022\u003ELoss of Ezh2 synergizes with JAK2-V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis\u003C\/a\u003E. \u003Ci\u003EThe Journal of Experimental Medicine\u003C\/i\u003E, \u003Ci\u003E213\u003C\/i\u003E(8), 1479-1496.","year":2016,"type":"Journal Article (Original Article)"},{"title":"Meyer, S. C., Keller, M. D., Chiu, S., Koppikar, P., Guryanova, O. A., Rapaport, F., Xu, K., Manova, K., Pankov, D., O\u2019Reilly, R. J., Kleppe, M., McKenney, A. S., Shih, A. H., Shank, K., Ahn, J., Papalexi, E., Spitzer, B., Socci, N., Viale, A., \u2026 Levine, R. L. (2015). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172394\u0022\u003ECHZ868, a Type II JAK2 Inhibitor, Reverses Type I JAK Inhibitor Persistence and Demonstrates Efficacy in Myeloproliferative Neoplasms\u003C\/a\u003E. \u003Ci\u003ECancer Cell\u003C\/i\u003E, \u003Ci\u003E28\u003C\/i\u003E(1), 15-28.","year":2015,"type":"Journal Article (Original Article)"},{"title":"Meyer, S. C., Keller, M. D., Woods, B. A., LaFave, L. M., Bastian, L., Kleppe, M., Bhagwat, N., Marubayashi, S., \u0026 Levine, R. L. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172395\u0022\u003EGenetic studies reveal an unexpected negative regulatory role for Jak2 in thrombopoiesis\u003C\/a\u003E. \u003Ci\u003EBlood\u003C\/i\u003E, \u003Ci\u003E124\u003C\/i\u003E(14), 2280-2284.","year":2014,"type":"Journal Article (Original Article)"},{"title":"Meyer, S. C., \u0026 Levine, R. L. (2014). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172397\u0022\u003ETranslational implications of somatic genomics in acute myeloid leukaemia.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EThe Lancet Oncology\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(9), e382-e394.","year":2014,"type":"Journal Article (Review)"},{"title":"Meyer, S. C., Medinger, M., Halter, J. P., Baldomero, H., Hirsch, H. H., Tzankov, A., Dirnhofer, S., Passweg, J. R., \u0026 Tichelli, A. (2014). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172400\u0022\u003EHeterogeneity in clinical course of EBV-associated lymphoproliferative disorder after allogeneic stem cell transplantation\u003C\/a\u003E. \u003Ci\u003EHematology\u003C\/i\u003E, \u003Ci\u003E19\u003C\/i\u003E(5), 280-285.","year":2014,"type":"Journal Article (Further Contribution)"},{"title":"Meyer, S. C., \u0026 Levine, R. L. (2014). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172398\u0022\u003EMolecular pathways: molecular basis for sensitivity and resistance to JAK kinase inhibitors.\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003EClinical Cancer Research\u003C\/i\u003E, \u003Ci\u003E20\u003C\/i\u003E(8), 2051-2059.","year":2014,"type":"Journal Article (Review)"},{"title":"Waibel, M., Solomon, V. S., Knight, D. A., Ralli, R. A., Kim, S.-K., Banks, K.-M., Vidacs, E., Virely, C., Sia, K. C. S., Bracken, L. S., Collins-Underwood, R., Drenberg, C., Ramsey, L. B., Meyer, S. C., Takiguchi, M., Dickins, R. A., Levine, R., Ghysdael, J., Dawson, M. A., \u2026 Johnstone, R. W. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172399\u0022\u003ECombined targeting of JAK2 and Bcl-2\/Bcl-xL to cure mutant JAK2-driven malignancies and overcome acquired resistance to JAK2 inhibitors\u003C\/a\u003E. \u003Ci\u003ECell Reports\u003C\/i\u003E, \u003Ci\u003E5\u003C\/i\u003E(4), 1047-1059.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Meyer, S. C., O\u2019Meara, A., Buser, A. S., Tichelli, A., Passweg, J. R., \u0026 Stern, M. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172401\u0022\u003EPrognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation\u003C\/a\u003E. \u003Ci\u003EBiology of Blood and Marrow Transplantation\u003C\/i\u003E, \u003Ci\u003E19\u003C\/i\u003E(3), 440-444.","year":2013,"type":"Journal Article (Original Article)"},{"title":"Meyer, S. C., Rov\u00f3, A., Tsakiris, D. A., Scherer, K., Tichelli, A., \u0026 Holbro, A. (2013). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172402\u0022\u003ESevere cutaneous toxicity related to Eltrombopag\u003C\/a\u003E. \u003Ci\u003EBritish Journal of Haematology\u003C\/i\u003E, \u003Ci\u003E160\u003C\/i\u003E(3), 412-414.","year":2013,"type":"Journal Article (Further Contribution)"},{"title":"Meyer, S. C. (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172404\u0022\u003E[Platelet inhibition in clinical practice]\u003C\/a\u003E. \u003Ci\u003ETherapeutische Umschau. Revue Therapeutique\u003C\/i\u003E, \u003Ci\u003E69\u003C\/i\u003E(11), 631-633.","year":2012,"type":"Journal Article (Further Contribution)"},{"title":"Scherer, S. R., Faber, K., Meyer, S. C., Ceschi, A., \u0026 Eckstein, J. (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172403\u0022\u003ESevere Bradycardia: Patient Outfoxed by Lady\u2019s Glove\u003C\/a\u003E. \u003Ci\u003EThe American Journal of Medicine\u003C\/i\u003E, \u003Ci\u003E125\u003C\/i\u003E(11), e3-e4.","year":2012,"type":"Journal Article (Further Contribution)"},{"title":"Forestier, M., Al-Tamimi, M., Gardiner, E. E., Hermann, C., Meyer, S. C., \u0026 Beer, J. H. (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172406\u0022\u003EDiesel exhaust particles impair platelet response to collagen and are associated with GPIb\u03b1 shedding\u003C\/a\u003E. \u003Ci\u003EToxicology in Vitro\u003C\/i\u003E, \u003Ci\u003E26\u003C\/i\u003E(6), 930-938.","year":2012,"type":"Journal Article (Original Article)"},{"title":"Meyer, S. C., Steveling, E. H., D\u2019Souza, M., \u0026 Hug, B. L. (2012). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172405\u0022\u003ESchmerzhafte Parese und Hautausschlag\u003C\/a\u003E. \u003Ci\u003ESwiss Medical Forum\u003C\/i\u003E, \u003Ci\u003E12\u003C\/i\u003E(36), 694-695.","year":2012,"type":"Journal Article (Further Contribution)"},{"title":"Meyer, S. C., \u0026 Stern, M. (2011). [Review of \u003Ci\u003E\u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/172407\u0022\u003E[Proteins support stem cells - use of protein therapeutics in hematopoietic stem cell transplantation].\u003C\/a\u003E\u003C\/i\u003E]. \u003Ci\u003ETherapeutische Umschau. Revue Therapeutique\u003C\/i\u003E, \u003Ci\u003E68\u003C\/i\u003E(11), 641-649.","year":2011,"type":"Journal Article (Review)"},{"title":"Kremer Hovinga Strebel, J. A., \u0026 Meyer, S. C. (2008). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/100330\u0022\u003ECurrent management of thrombotic thrombocytopenic purpura\u003C\/a\u003E. \u003Ci\u003ECurrent Opinion in Hematology\u003C\/i\u003E, \u003Ci\u003E15\u003C\/i\u003E(5), 445-50.","year":2008,"type":"Journal Article (Further Contribution)"},{"title":"Meyer, S. C., Jeddi, R., Meddeb, B., Gouider, E., L\u00e4mmle, B., \u0026 Kremer Hovinga Strebel, J. A. (2008). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/100328\u0022\u003EA first case of congenital TTP on the African continent due to a new homozygous mutation in the catalytic domain of ADAMTS13\u003C\/a\u003E. \u003Ci\u003EAnnals of Hematology\u003C\/i\u003E, \u003Ci\u003E87\u003C\/i\u003E(8), 663-6.","year":2008,"type":"Journal Article (Further Contribution)"},{"title":"Meyer, S. C., Sulzer, I., L\u00e4mmle, B., \u0026 Kremer Hovinga Strebel, J. A. (2007). \u003Ca target=\u0022_blank\u0022 href=\u0022https:\/\/boris-portal.unibe.ch\/handle\/20.500.12422\/96559\u0022\u003EHyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay: diagnostic relevance in patients suffering from acute thrombotic microangiopathies\u003C\/a\u003E. \u003Ci\u003EJournal of Thrombosis and Haemostasis\u003C\/i\u003E, \u003Ci\u003E5\u003C\/i\u003E(4), 866-7.","year":2007,"type":"Journal Article (Original Article)"}]}
